A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. Medtronic was founded in 1949 and today serves healthcare systems, physicians, clinicians, and patients in more than 150 countries worldwide. We remain committed to a mission written by our founder in 1960 that directs us “to contribute to human welfare by the application of biomedical engineering in the research, design, manufacture, and sale of products to alleviate pain, restore health, and extend life.” Our Mission — to alleviate pain, restore health, and extend life — empowers us to engineer the extraordinary and deliver better outcomes for our world. We are a company of dedication, honesty, integrity, and service.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 35.5B | 33.5B | 32.4B | 31.2B | 31.7B | 30.1B |
| Net Income | 4.6B | 4.7B | 3.7B | 3.8B | 5.0B | 3.6B |
| EPS | $3.58 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 |
| Free Cash Flow | 5.4B | 5.2B | 5.2B | 4.6B | 6.0B | 4.9B |
| ROIC | 7.3% | 7.2% | 5.8% | 5.7% | 7.6% | 6.2% |
| Gross Margin | 64.9% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% |
| Debt/Equity | 0.58 | 0.65 | 0.52 | 0.47 | 0.53 | 0.51 |
| Dividends/Share | $2.83 | $2.80 | $2.76 | $2.72 | $2.52 | $2.32 |
| Operating Income | 6.0B | 6.0B | 5.1B | 5.5B | 5.8B | 4.5B |
| Operating Margin | 17.0% | 17.8% | 15.9% | 17.6% | 18.2% | 14.9% |
| ROE | 9.4% | 9.5% | 7.3% | 7.3% | 9.6% | 7.0% |
| Shares Outstanding | 1,284M | 1,291M | 1,332M | 1,333M | 1,351M | 1,356M |
Medtronic plc passes 4 of 9 quality checks, suggesting mixed fundamentals.
Medtronic plc trades at 24.6x trailing earnings, compared to its 15-year median P/E of 25.2x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 20.9x vs a median of 20.9x. The company's 5-year average ROIC is 6.5% with a gross margin of 65.9%. Total shareholder yield (dividends + buybacks) is 4.0%. At current prices, the estimated annualized return to fair value is -0.3%.
Medtronic plc (MDT) has a current P/E ratio of 24.6, compared to its historical median P/E of 25.2. The stock is currently considered Fair based on its historical valuation range.
Medtronic plc (MDT) has a 5-year average return on invested capital (ROIC) of 6.5%. This is below average and may indicate limited pricing power.
Medtronic plc (MDT) has a market capitalization of $113.0B. It is classified as a large-cap stock.
Yes, Medtronic plc (MDT) pays a dividend with a trailing twelve-month yield of 3.21%. The company also returns capital through share buybacks, with a buyback yield of 0.77%.
Based on historical P/E analysis, Medtronic plc (MDT) appears fair. The current P/E of 24.6 is 3% below its historical median of 25.2. The estimated fair value CAGR (P/E method) is 0.5%.
Medtronic plc (MDT) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
Medtronic plc (MDT) reported annual revenue of $33.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
Medtronic plc (MDT) has a net profit margin of 13.9%. This is a healthy margin.
Medtronic plc (MDT) generated $5.2 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Medtronic plc (MDT) has a debt-to-equity ratio of 0.65. This indicates moderate leverage.
Medtronic plc (MDT) reported earnings per share (EPS) of $3.61 in its most recent fiscal year.
Medtronic plc (MDT) has a return on equity (ROE) of 9.5%. This indicates moderate shareholder returns.
Medtronic plc (MDT) has a 5-year average gross margin of 65.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 13 years of financial data for Medtronic plc (MDT), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Medtronic plc (MDT) has a book value per share of $37.19, based on its most recent annual SEC filing.